Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, and initial efficacy of a single intravenous infusion of JWK007 in Duchenne Muscular Dystrophy (DMD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• JWK007

Snippet

Sponsor: West China Hospital | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: ACTIVE_NOT_RECRUITING